Answer
Dry mouth was reported in 9.5% of patients in clinical studies of Vesomni (solifenacin + tamsulosin), making it the most frequently reported adverse reaction.
Sources for this answer
- Vesomni 6 mg/0.4 mg modified release tabletsAstellas Pharma Ltd · emc · SmPC §4.8 Undesirable effects · Version 4Document updated
Sources checked